| 1 |
35512857 | Effects of 1,5-anhydro-D-glucitol on insulin secretion both in in vitro and ex vivo pancreatic preparations. | 2022 Jun |
4 |
| 2 |
34167955 | Saliva 1,5-anhydroglucitol is associated with early-phase insulin secretion in Chinese patients with type 2 diabetes. | 2021 Jun |
3 |
| 3 |
27246285 | 1,5-Anhydro-D-Glucitol Could Reflect Hypoglycemia Risk in Patients with Type 2 Diabetes Receiving Insulin Therapy. | 2016 Jun |
1 |
| 4 |
26172028 | Low levels of C-peptide have clinical significance for established Type 1 diabetes. | 2015 Oct |
1 |
| 5 |
22421598 | Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs. | 2012 Jun |
1 |
| 6 |
22731793 | Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy. | 2012 Sep |
1 |
| 7 |
19254570 | The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. | 2009 Mar |
1 |
| 8 |
19620188 | Screening for type 2 diabetes in obese youth. | 2009 Aug |
1 |
| 9 |
2244184 | 1,5-Anhydro-D-glucitol--a novel type of sugar in the human organism. | 1990 |
1 |
| 10 |
6360421 | Serum 1,5-anhydroglucitol concentration in diabetic patients receiving a continuous subcutaneous infusion of insulin. | 1984 Jan |
1 |
| 11 |
6345028 | Variations of 1-deoxyglucose(1,5-anhydroglucitol) content in plasma from patients with insulin-dependent diabetes mellitus. | 1983 Jul |
2 |